RaySearch Laboratories AB (publ) Asset Resilience Ratio
RaySearch Laboratories AB (publ) asset resilience ratio. RaySearch Laboratories AB (publ) (RAY-B) has an Asset Resilience Ratio of 20.45% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See RaySearch Laboratories AB (publ) defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of RaySearch Laboratories AB (publ) (2003–2025)
Asset resilience ratio of RaySearch Laboratories AB (publ) from 2003 to 2025. This chart shows how RaySearch Laboratories AB (publ)'s Asset Resilience Ratio has changed over time. Read RaySearch Laboratories AB (publ) (RAY-B) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down RaySearch Laboratories AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see RaySearch Laboratories AB (publ) (RAY-B) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr407.30 Million | 20.45% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr407.30 Million | 20.45% |
Asset Resilience Insights
- Good Liquidity Position: RaySearch Laboratories AB (publ) maintains a healthy 20.45% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
RaySearch Laboratories AB (publ) Industry Peers by Asset Resilience Ratio
Compare RaySearch Laboratories AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
Intrasense
PA:ALINS |
Health Information Services | 15.68% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 17.07% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 32.70% |
|
Alcidion Group Ltd
AU:ALC |
Health Information Services | 32.45% |
|
Oneview Healthcare Plc
AU:ONE |
Health Information Services | 29.71% |
|
AMA Corp PLC
PA:ALAMA |
Health Information Services | 63.85% |
RaySearch Laboratories AB (publ) Asset Resilience Ratio by Year (2003–2025)
RaySearch Laboratories AB (publ) asset resilience ratio by year from 2003 to 2025. The table below shows the annual Asset Resilience Ratio data for RaySearch Laboratories AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 20.45% | Skr407.30 Million ≈ $43.83 Million |
Skr1.99 Billion ≈ $214.37 Million |
-1.68pp |
| 2024-12-31 | 22.13% | Skr462.74 Million ≈ $49.80 Million |
Skr2.09 Billion ≈ $225.04 Million |
+4.53pp |
| 2023-12-31 | 17.60% | Skr343.68 Million ≈ $36.99 Million |
Skr1.95 Billion ≈ $210.14 Million |
+9.06pp |
| 2022-12-31 | 8.54% | Skr160.27 Million ≈ $17.25 Million |
Skr1.88 Billion ≈ $201.88 Million |
+2.65pp |
| 2021-12-31 | 5.90% | Skr102.53 Million ≈ $11.03 Million |
Skr1.74 Billion ≈ $187.15 Million |
-7.24pp |
| 2020-12-31 | 13.13% | Skr168.75 Million ≈ $18.16 Million |
Skr1.28 Billion ≈ $138.28 Million |
+4.13pp |
| 2019-12-31 | 9.01% | Skr113.86 Million ≈ $12.25 Million |
Skr1.26 Billion ≈ $136.05 Million |
+0.49pp |
| 2004-12-31 | 8.51% | Skr3.87 Million ≈ $416.15K |
Skr45.42 Million ≈ $4.89 Million |
-8.65pp |
| 2003-12-31 | 17.17% | Skr5.28 Million ≈ $568.21K |
Skr30.76 Million ≈ $3.31 Million |
-- |
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment co… Read more